Logo image of WAY

WAYSTAR HOLDING CORP (WAY) Stock Fundamental Analysis

USA - NASDAQ:WAY - US9467841055 - Common Stock

39.62 USD
+0.13 (+0.33%)
Last: 10/29/2025, 5:20:26 PM
39.62 USD
0 (0%)
After Hours: 10/29/2025, 5:20:26 PM
Fundamental Rating

5

WAY gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. WAY has an average financial health and profitability rating. WAY is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year WAY was profitable.
In the past year WAY had a positive cash flow from operations.
WAY Yearly Net Income VS EBIT VS OCF VS FCFWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

WAY has a Return On Assets of 1.84%. This is amongst the best in the industry. WAY outperforms 88.57% of its industry peers.
WAY's Return On Equity of 2.71% is amongst the best of the industry. WAY outperforms 88.57% of its industry peers.
WAY's Return On Invested Capital of 3.67% is fine compared to the rest of the industry. WAY outperforms 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for WAY is below the industry average of 6.80%.
The 3 year average ROIC (2.09%) for WAY is below the current ROIC(3.67%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.84%
ROE 2.71%
ROIC 3.67%
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
WAY Yearly ROA, ROE, ROICWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 1 -1 2 -2

1.3 Margins

The Profit Margin of WAY (8.50%) is better than 94.29% of its industry peers.
WAY's Operating Margin of 20.80% is amongst the best of the industry. WAY outperforms 94.29% of its industry peers.
In the last couple of years the Operating Margin of WAY has grown nicely.
WAY has a better Gross Margin (67.32%) than 62.86% of its industry peers.
WAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 20.8%
PM (TTM) 8.5%
GM 67.32%
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
WAY Yearly Profit, Operating, Gross MarginsWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 40 60

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WAY is destroying value.
Compared to 1 year ago, WAY has more shares outstanding
The debt/assets ratio for WAY has been reduced compared to a year ago.
WAY Yearly Shares OutstandingWAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
WAY Yearly Total Debt VS Total AssetsWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.42 indicates that WAY is not in any danger for bankruptcy at the moment.
The Altman-Z score of WAY (3.42) is better than 71.43% of its industry peers.
The Debt to FCF ratio of WAY is 4.45, which is a neutral value as it means it would take WAY, 4.45 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of WAY (4.45) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.39 indicates that WAY is not too dependend on debt financing.
WAY has a worse Debt to Equity ratio (0.39) than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.45
Altman-Z 3.42
ROIC/WACC0.38
WACC9.57%
WAY Yearly LT Debt VS Equity VS FCFWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 3.43 indicates that WAY has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.43, WAY is doing good in the industry, outperforming 77.14% of the companies in the same industry.
A Quick Ratio of 3.43 indicates that WAY has no problem at all paying its short term obligations.
WAY has a better Quick ratio (3.43) than 77.14% of its industry peers.
Industry RankSector Rank
Current Ratio 3.43
Quick Ratio 3.43
WAY Yearly Current Assets VS Current LiabilitesWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 199.63% over the past year.
The Revenue has grown by 17.14% in the past year. This is quite good.
WAY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.71% yearly.
EPS 1Y (TTM)199.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)17.14%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%15.4%

3.2 Future

WAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 78.47% yearly.
WAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.91% yearly.
EPS Next Y343.67%
EPS Next 2Y122.86%
EPS Next 3Y78.47%
EPS Next 5YN/A
Revenue Next Year12.33%
Revenue Next 2Y11.79%
Revenue Next 3Y11.91%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
WAY Yearly Revenue VS EstimatesWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
WAY Yearly EPS VS EstimatesWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 35.69, which means the current valuation is very expensive for WAY.
Based on the Price/Earnings ratio, WAY is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
WAY's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.00.
The Price/Forward Earnings ratio is 25.15, which means the current valuation is very expensive for WAY.
80.00% of the companies in the same industry are more expensive than WAY, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, WAY is valued at the same level.
Industry RankSector Rank
PE 35.69
Fwd PE 25.15
WAY Price Earnings VS Forward Price EarningsWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

WAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. WAY is cheaper than 74.29% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, WAY is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 27.15
EV/EBITDA 22.34
WAY Per share dataWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

WAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of WAY may justify a higher PE ratio.
WAY's earnings are expected to grow with 78.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y122.86%
EPS Next 3Y78.47%

0

5. Dividend

5.1 Amount

No dividends for WAY!.
Industry RankSector Rank
Dividend Yield N/A

WAYSTAR HOLDING CORP

NASDAQ:WAY (10/29/2025, 5:20:26 PM)

After market: 39.62 0 (0%)

39.62

+0.13 (+0.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners69.9%
Inst Owner Change1.31%
Ins Owners1.26%
Ins Owner Change0.52%
Market Cap7.56B
Revenue(TTM)1.01B
Net Income(TTM)85.94M
Analysts86
Price Target50.64 (27.81%)
Short Float %6.03%
Short Ratio2.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.52%
Min EPS beat(2)-1.27%
Max EPS beat(2)6.31%
EPS beat(4)3
Avg EPS beat(4)34.74%
Min EPS beat(4)-1.27%
Max EPS beat(4)103.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.16%
Min Revenue beat(2)2.36%
Max Revenue beat(2)3.95%
Revenue beat(4)4
Avg Revenue beat(4)4.17%
Min Revenue beat(4)2.36%
Max Revenue beat(4)6.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.25%
PT rev (3m)3.06%
EPS NQ rev (1m)1.14%
EPS NQ rev (3m)6.43%
EPS NY rev (1m)0.19%
EPS NY rev (3m)4.66%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)1.24%
Revenue NY rev (1m)0.57%
Revenue NY rev (3m)2.72%
Valuation
Industry RankSector Rank
PE 35.69
Fwd PE 25.15
P/S 7.48
P/FCF 27.15
P/OCF 24.83
P/B 2.38
P/tB N/A
EV/EBITDA 22.34
EPS(TTM)1.11
EY2.8%
EPS(NY)1.58
Fwd EY3.98%
FCF(TTM)1.46
FCFY3.68%
OCF(TTM)1.6
OCFY4.03%
SpS5.3
BVpS16.62
TBVpS-4.35
PEG (NY)0.1
PEG (5Y)N/A
Graham Number20.38
Profitability
Industry RankSector Rank
ROA 1.84%
ROE 2.71%
ROCE 4.65%
ROIC 3.67%
ROICexc 3.97%
ROICexgc 91.57%
OM 20.8%
PM (TTM) 8.5%
GM 67.32%
FCFM 27.55%
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
ROICexc(3y)2.13%
ROICexc(5y)N/A
ROICexgc(3y)47.51%
ROICexgc(5y)N/A
ROCE(3y)2.64%
ROCE(5y)N/A
ROICexgc growth 3Y7.56%
ROICexgc growth 5YN/A
ROICexc growth 3Y30.65%
ROICexc growth 5YN/A
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
F-Score8
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.45
Debt/EBITDA 3.27
Cap/Depr 15.78%
Cap/Sales 2.57%
Interest Coverage 250
Cash Conversion 81.15%
Profit Quality 324.12%
Current Ratio 3.43
Quick Ratio 3.43
Altman-Z 3.42
F-Score8
WACC9.57%
ROIC/WACC0.38
Cap/Depr(3y)12.11%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)199.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y343.67%
EPS Next 2Y122.86%
EPS Next 3Y78.47%
EPS Next 5YN/A
Revenue 1Y (TTM)17.14%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%15.4%
Revenue Next Year12.33%
Revenue Next 2Y11.79%
Revenue Next 3Y11.91%
Revenue Next 5YN/A
EBIT growth 1Y85.59%
EBIT growth 3Y27.06%
EBIT growth 5YN/A
EBIT Next Year134.75%
EBIT Next 3Y42.44%
EBIT Next 5YN/A
FCF growth 1Y375.9%
FCF growth 3Y15.76%
FCF growth 5YN/A
OCF growth 1Y229.9%
OCF growth 3Y16.85%
OCF growth 5YN/A

WAYSTAR HOLDING CORP / WAY FAQ

What is the fundamental rating for WAY stock?

ChartMill assigns a fundamental rating of 5 / 10 to WAY.


What is the valuation status for WAY stock?

ChartMill assigns a valuation rating of 5 / 10 to WAYSTAR HOLDING CORP (WAY). This can be considered as Fairly Valued.


Can you provide the profitability details for WAYSTAR HOLDING CORP?

WAYSTAR HOLDING CORP (WAY) has a profitability rating of 6 / 10.


What is the financial health of WAYSTAR HOLDING CORP (WAY) stock?

The financial health rating of WAYSTAR HOLDING CORP (WAY) is 6 / 10.